Nymox Pharmaceutical Corp operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nymox Pharmaceutical Corp with three other
pharmaceutical manufacturers in North America:
Titan Pharmaceuticals Inc
of the United States
sales of $215,000.00
of which 100%
was Development of Pharmaceutical Products),
Stellar Biotechnologies, Inc.
(299,302.52 Canadian Dollars [US$227,781.19 ]
Amarillo Biosciences, Inc.
based in the United States
During the year ended December of 2017, sales at
Nymox Pharmaceutical Corp were C$290,091.20 (US$220.77 thousand).
decrease of 22.6%
versus 2016, when the company's sales were C$374,746.56 .